Papers
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7160.703 (Published 12 September 1998) Cite this as: BMJ 1998;317:703
Related articles
- Editor's Choice [GP] Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.0a
- This Week In The BMJ Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.0b
- Editorial Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.691
- Editorial Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.693
- Paper Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.713
- Paper Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.720
- Clinical Review Published: 31 August 2006; BMJ 333 doi:10.1136/bmj.38922.650521.80
- Editorial Published: 12 February 2009; BMJ 338 doi:10.1136/bmj.b441
- Research Published: 30 August 2012; BMJ 345 doi:10.1136/bmj.e5567
- Research Published: 03 October 2013; BMJ 347 doi:10.1136/bmj.f5680
- Research Published: 28 October 2015; BMJ 351 doi:10.1136/bmj.h5364
- Clinical Review Published: 21 November 2016; BMJ 355 doi:10.1136/bmj.i5719
- Letter Published: 06 April 2002; BMJ 324 doi:10.1136/bmj.324.7341.849
See more
- Semaglutide’s CVD indication could cost US Medicare $145bn extra a yearBMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878
- Semaglutide: UK regulator approves drug for prevention of cardiovascular eventsBMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660
- Why India is failing to track heatstroke fatalities properlyBMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437
- Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rulesBMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424
- Sixty seconds on . . . flyingBMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266